👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 95/100
Accepting new patients
Dr
Dr Mary Mccormack
Oncology
English
6,951+
Patients seen
2
Years in practice
6
Publications
1
Languages spoken
About
Dr Mary McCormack is a Consultant Clinical Oncologist, specialising in gynaecological and breast cancers. She qualified in medicine from Guy's and St Thomas' Hospital. Before medical school, she undertook research in radiation biology and was awarded a PhD in 1989. Dr McCormack has worked in leading London cancer centres and in 2000, she was awarded the FRCR in clinical oncology. She was appointed a consultant at University College London Hospital in 2002.
Dr McCormack treats all subtypes of gynaecological cancer, including ovary, womb, uterus, cervix, vulva, vagina and also treats breast cancer. Treatments include chemotherapy, targeted/ biological therapy, radiotherapy and brachytherapy. She has a particular interest in cervical cancer treatment and targeted agents in breast, ovarian and endometrial cancer. Dr McCormack is a major contributor to national and international clinical trials and is the chief investigator on a nuber of studies. She is the current chair of the international Cervical Cancer Research Network (CCRN)and an executive member of the Gynaecologic Cancer Intergroup (GCIG)and a member of the International Gynaecologic Cancer Society's education committee.She is also a member of the ASCO International Affairs Committee.
Dr. Mccormack has expertise in the following areas:
• Radiotherapy
• Chemotherapy
• Brachytherapy
• Cervical Cancer
• Breast Cancer
• Gynaecological Cancers
• Uterine cancer
• Vaginal and vulval cancer
• Ovarian cancer
• Biological therapy
Dr McCormack treats all subtypes of gynaecological cancer, including ovary, womb, uterus, cervix, vulva, vagina and also treats breast cancer. Treatments include chemotherapy, targeted/ biological therapy, radiotherapy and brachytherapy. She has a particular interest in cervical cancer treatment and targeted agents in breast, ovarian and endometrial cancer. Dr McCormack is a major contributor to national and international clinical trials and is the chief investigator on a nuber of studies. She is the current chair of the international Cervical Cancer Research Network (CCRN)and an executive member of the Gynaecologic Cancer Intergroup (GCIG)and a member of the International Gynaecologic Cancer Society's education committee.She is also a member of the ASCO International Affairs Committee.
Dr. Mccormack has expertise in the following areas:
• Radiotherapy
• Chemotherapy
• Brachytherapy
• Cervical Cancer
• Breast Cancer
• Gynaecological Cancers
• Uterine cancer
• Vaginal and vulval cancer
• Ovarian cancer
• Biological therapy
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mary Mccormack
Education & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncology
Career & appointments
-
2027-09–2028-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,081 |
| Annual physical exam | 99395 | 1,231 |
| Vaccination administration | 90471 | 2,303 |
| Minor procedure (skin) | 17110 | 2,936 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 720.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 630.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 3 · i10: 13
-
Long-term follow-up of Oncology across GB
DOI: 10.6859/euroclin.2026.0 · PMID: 31814347 · cited by 145
-
Validation of clinical scoring in Oncology
DOI: 10.7291/euroclin.2025.1 · PMID: 34058212 · cited by 139
-
Long-term follow-up of Oncology across GB
DOI: 10.4798/euroclin.2024.2 · PMID: 31419083 · cited by 29
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2028
- national college of family doctors — Member · since 2028
- European Union of Medical Specialists (UEMS) — Member · since 2028
Patient reviews
- Bedside Manner
- 4.87
- Knowledge
- 4.90
- Wait Time
- 4.57
- Staff Friendliness
- 4.84
- Ease Of Appointment
- 4.72
- Value For Money
- 4.74
- Would Recommend Pct
- 96
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.mary.mccormack@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
